Lyndra Therapeutics Doses First Clinical Trial Participant in Pivotal Study of Oral Weekly Risperidone (LYN-005) for Schizophrenia and Schizoaffective Disorder

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Source:
    Business Wire (English), 05/09/2023